Member Info for Professor1

People talk down the share when they have missed a big opportunity, grief of having lost out big time and now costing them more

GLA

LSBM - thank you for summarising so well.

GLA

Deal any day

GLA

Super duper, so glad bought lots last month.

GLA

Hi Tiger16

I have an opposite view in that, as this is/ will be a first mover advantage, I think there may be a bidding war and hence IMM has an upper hand and based on what the management's understanding of what the product can deliver, they are going to set the price bar very high

Tim mentioned in the interview that he himself suffers from Thyroid problems. The Thyroid market alone is well over 200 million people. My consultant once mentioned to me that Thyroid was one of the most common problems in the UK, Imagine the amount NHS could save each year.

GLA

Sorry PK73, just realised he was here last week

Hi PK73

I have other commitments so unfortunately cannot make it.

@spantrout

"ImmuPharma's novel diagnostic test, designed to identify patients with Type M immune disorder, not only strengthens the value proposition of P140 but also creates an independent commercial opportunity with potential for earlier adoption and partnerships"

The way I see this is that Immupharma can entertain other partnerships in the US other than with Avion.

GLA

Been trying to buy on HL but can't

Wow, just listened to the latest interview. This is going to massive - P140 could become part of a normal annual health check at your local surgery.

I would not be surprised if some of those big pharma companies are there US ones.

So glad to be in this one.

GLA

This will seriously move upwards with the hint of an initial strategic investment by any major or even GGP.

GLA

@TOMHH

Agreed. Saw the interview and topped up yesterday just before close, extremely difficult to buy

Thyroid disease is an umbrella term encompassing various conditions that affect the function, size, or structure of the thyroid, mainly including hyperthyroidism, hypothyroidism, thyroid nodules, autoimmune thyroid disease, and thyroid cancer.1 It is estimated that approximately 200 million people worldwide were diagnosed with thyroid disease.2 According to the survey, the prevalence of overt hyperthyroidism in areas with sufficient iodine ranges from 0.2% to 1.3%, while the prevalence of hypothyroidism ranges from 1% to 2%.3 Moreover, the proportion of palpable thyroid nodules in the general population accounts for 4% to 7%.4

When is the right time to consider listing in the US and how expensive this would be?

Hi Stever

Had messaged Mark earlier in the week. He is currently in West Africa but will be passing through London. I will be speaking to him on the 4th Sept

The 2D visual photo cannot give us the grams per tonne gold. One needs to consider the depth / volume of the core, hence lab analysis

Got my foot in here. Had to purchase several times as could not buy in one lot on HL

GLA

RNS out

The management obviously know the great potential that may be ahead and doing nothing not an option in this scenario